# Hemadsorption During and After Cardiopulmonary Bypass to Modulate the Inflammatory Response

> **NCT04157647** · NA · UNKNOWN · sponsor: **University Magna Graecia** · enrollment: 40 (estimated)

## Conditions studied

- Inflammatory Response
- Chronic Renal Disease
- Cardiac Surgery

## Interventions

- **DEVICE:** CytoSorb
- **DEVICE:** Control

## Key facts

- **NCT ID:** NCT04157647
- **Lead sponsor:** University Magna Graecia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-15
- **Primary completion:** 2021-11-01
- **Final completion:** 2021-11-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04157647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04157647, "Hemadsorption During and After Cardiopulmonary Bypass to Modulate the Inflammatory Response". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04157647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*